Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Immunodiagnostic Expects Further Revenue Fall In Current Year

29th May 2015 06:58

LONDON (Alliance News) - Immunodiagnostic Systems Holdings PLC said Friday it expects revenue to continue to fall in its current year, and revenue in its recently ended financial year to be in line with previous guidance.

The company, which provides clinical laboratory diagnostic services, expects to post revenue of GBP45 million for the year to end-March 2015, compared to GBP52 million a year before. This is in line with guidance it provided in April. At the time, it attributed the decline to a lower level of its instruments being placed with end customers by distributors.

It expects revenue to fall further in its current year to end-March 2016 to a range between GBP39 million and GBP42 million.

Immunodiagnostic will announce its final results June 23. It said it remains committed to executing its strategic plan, and will provide further updates on its strategic objectives with its full year results.

By Hana Stewart-Smith; [email protected]; @HanaSSAllNews

Copyright 2015 Alliance News Limited. All Rights Reserved.


Related Shares:

IDH.L
FTSE 100 Latest
Value8,320.12
Change44.46